✦ LIBER ✦

Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors

✍ Scribed by Samir D. Undevia; Nicholas J. Vogelzang; Ann M. Mauer; Linda Janisch; Sridhar Mani; Mark J. Ratain

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

108 POSTER Phase I study of ABT869, a mu

✍ B.C. Goh; C.H. Thang; N. Sukri; C.I. Wong; R. Soo; R. Carr; S.C. Lee; C.S. Chen; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 62 KB

A phase I trial of vinorelbine in combin

✍ Nancy W. Peacock; Howard A. Burris; Veronique Dieras; Lon Smith; Gladys I. Rodri 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 87 KB

P-359 Results from a phase I study of th

✍ Wheeler, Catherine; Minami, Hironobu; Ebi, Hiromichi; Tahara, Makoto; Sasaki, Ya 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 189 KB

Effects of ZD6474, an orally active inhi

✍ S. Holden; S. Eckhardt; R. Basser; D. Rischin; H. Hurwitz; R. DeBoer; M. Rosenth 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 189 KB

A phase I trial of gemcitabine plus pacl

✍ Sandler, A.; Raghavan, D.; Meropol, N.; Meyers, T.; Kindler, H.; Fox, S.; Perez, 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 250 KB

Phase I study of AG 331, a novel thymidy

✍ Robert T. Koda; Agustin A. Garcia; Dhruba J. Chatterjee; Wen Yen Li; Deepika Par 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 153 KB